Our teaching organization and faculty are excited to work with a company of this stature and believe this will give Empire an opportunity to showcase more of the newest aesthetic products within our programs for physicians to learn on first hand.
(PRWEB) November 23, 2015
Empire Medical Training announced a new partnership with Merz North America today. The partnership is a facilitated agreement to introduce the newest aesthetic products and technologies to Empire participants. This announcement was delivered today during the Empire Botox Training workshop attended by over 250 physicians.
Dr. Stephen Cosentino, DO, President and Founder of the company stated, “Our teaching organization and faculty are excited to work with a company of this stature and believe this will give Empire an opportunity to showcase more of the newest aesthetic products within our programs for physicians to learn on first hand.”
Empire will provide training for physicians on products such as Radiesse®, Belotero Balance®, and Asclera®. In addition to their injectable line of aesthetic products, the company will introduce the Ultherapy® technology and other cosmetic lasers (and manufacturers) during the cosmetic laser training courses. Merz Aesthetics offers innovative devices, injectable and skincare products including: Ulthera®, Celfina®, Radiesse®, Belotero®, Xeomin® and Neocutis®. During Empire’s facial aesthetics workshop, Neocutis® will be presented along with a comprehensive array of skin care products.
Aesthetics is a competitive field so it is prudent for the practitioner to manage overhead and cut costs. Botulinum Toxin Type A injections can be highly profitable for the practitioner; however, Botulinum Toxin Type A injections are expensive. When practitioners have to pay over $550 per 100 unit bottle, it can become challenging to generate a sizable profit for the practice.
Empire has negotiated special pricing with Merz North America for all members, graduates, and attendees to the company’s courses. The Xeomin® product, which is incobotulinumtoxin A, is an excellent choice for practitioners just getting started in Aesthetics as well as for established Practitioners. With savings of over $100 per 100u vial, Xeomin® is becoming the number one choice for Cosmetic Physicians and practitioners. Lowering the cost per unit of Botulinum Toxin Type A dramatically impacts the practitioner’s bottom line.
The company’s partnership with Merz North America coincides with Empire’s initial steps to expand into Asia, Australia, South America, and the Middle East. Dr. James Avellini, MD cosmetic surgeon and instructor for the company stated that “as Empire moves into countries abroad, more and more physicians will be exposed to the newest technologies currently available in aesthetics, and this benefits everyone.”
Empire is an accredited medical education organization that trains health care practitioners on a variety of medical procedures and office based treatment modalities. The company is the pioneer in providing training and education on office based procedures and interventional modalities for primary care practitioners.
Now in their 18th year, Empire boasts having graduated over 45,000 health care professionals. The company provides training in over 32 areas of medicine such as aesthetic medicine, interventional pain management, surgery, and practice management and marketing. Empire provides over 700 workshops annually throughout the United States, Asia, Australia, South America, and will be expanding to Europe and The Middle East during Q4- 2015.
For additional information, contact an Empire representative at 866-366-1576 or visit http://www.EmpireMedicalTraining.com, or email Merz North America at empire(at)merz.com
About Merz North America:
Merz Pharma is an international healthcare company and remains the leader in aesthetics, dermatology and the neuroscience market. Based in Germany, the US Subsidiary of Merz Pharma GmbH and Co is Merz Pharmaceuticals LLC and is located in Raleigh, North Carolina.